Novel class of molecules --the SGRMs-- with potential therapeutic benefits over glucocorticoids June 22, 2001
Orally active SARM exerts anabolic effects on bone and muscle in androgen-deficient rats June 22, 2001
Valdecoxib compares favorably to conventional NSAIDs in terms of both efficacy and safety June 22, 2001
RSS